Mavacamten in Symptomatic Patients Resistant to Previous Advanced Therapy for Obstructive Hypertrophic Cardiomyopathy

Background The clinical benefits of mavacamten in patients with obstructive hypertrophic cardiomyopathy previously treated with advanced therapies are not established. Methods Clinical and echocardiographic outcomes of patients treated with mavacamten for left ventricular outflow obstruction for at...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Daniele Massera, Elizabeth Adlestein, Sumar Frejat, Woon Y. Wu, Maria C. Reuter, Yuhe Xia, Isabel C. Alvarez, Mark V. Sherrid
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2025-08-01
Schriftenreihe:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Schlagworte:	cardiac myosin inhibitor hypertrophic cardiomyopathy left ventricular outflow obstruction
Online-Zugang:	https://www.ahajournals.org/doi/10.1161/JAHA.125.041565
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!